openPR Logo
Press release

Prader-Willi Syndrome Market to Drive Growth with Prominent Players by 2024-2031 - Novartis, Soleno Therapeutics, Saniona

Prader-Willi Syndrome Market

Prader-Willi Syndrome Market

DataM Intelligence has released a new research report on the Prader-Willi Syndrome market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits, gross margins, and strategic decisions in the global market. The report is enriched with tables, charts, and infographics for a clear presentation of the findings.

Prader-Willi syndrome market is expected to grow at a CAGR of 4.5% in the forecast period (2024-2031).

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/prader-willi-syndrome-market

Prader-Willi Syndrome (PWS) is a genetic disorder caused by the loss of function of specific genes on chromosome 15, typically due to paternal deletion or maternal uniparental disomy. This condition is characterized by a range of physical, mental, and behavioral challenges. Key features include hyperphagia (an insatiable appetite leading to obesity), developmental delays, intellectual disability, and distinctive physical traits such as short stature and hypotonia (decreased muscle tone). Individuals with PWS may also experience emotional and behavioral issues, including temper outbursts and obsessive-compulsive behaviors. Early diagnosis and intervention are critical for managing symptoms, which often include a combination of dietary management, hormone therapy (such as growth hormone), and support for developmental and behavioral challenges. While there is no cure, comprehensive care can significantly improve the quality of life for those affected by PWS.

List of the Key Players in the Prader-Willi Syndrome Market:

Novartis, Soleno Therapeutics, Saniona, Pfizer, Millendo Therapeutics, Inc., Levo Therapeutics, Inc., Rhythm Pharmaceuticals, Essentialis, Inc., LG Corp and Novo Nordisk.

Key Developments:

On July 20, 2022, the FDA recognized that data from the randomized withdrawal period of Study C602 conducted by Soleno Therapeutics could potentially support a New Drug Application (NDA) submission.

Research Process:

Both primary and secondary data sources have been used in the global Prader-Willi Syndrome Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Prader-Willi Syndrome Market:

By Product Type: Recombinant growth hormone, Beloranib, Betahistine Hydrochloride, Diazoxide Choline CR, FE-992097, Others.

By End-user: Hospitals, Clinics, Others.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/prader-willi-syndrome-market

Regional Analysis:

➣ North America (US, Canada, Mexico)

➣ Europe (Germany, Russia, UK, France, Italy, Spain, Rest of Europe)

➣ Asia-Pacific (China, India, Japan, Australia, Rest of Asia Pacific)

➣ South America (Brazil, Argentina, Rest of South America)

➣ Middle East and Africa

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Prader-Willi Syndrome market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Prader-Willi Syndrome Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Prader-Willi Syndrome market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Prader-Willi Syndrome Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/prader-willi-syndrome-market

The Research Report Offers Answers To The Following Questions:

☛ What is the expected growth rate of the global market for the forecast period?

☛ What are the key driving factors that are responsible to shape the fate of the Prader-Willi Syndrome market during the forecast period?

☛ What will be the overall size of the market during the analysis period?

☛ What are the prominent market trends which influence the development of the Prader-Willi Syndrome market across various regions?

☛ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☛ What are the challenges and threats that are likely to act as a barrier to the growth of the Prader-Willi Syndrome market?

☛ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prader-Willi Syndrome Market to Drive Growth with Prominent Players by 2024-2031 - Novartis, Soleno Therapeutics, Saniona here

News-ID: 3696279 • Views:

More Releases from DataM Intelligence 4market Research LLP

Pharmaceuticals Market to Reach US$ 3.18 Trillion by 2033, Fueled by Biologics and Personalized Medicine
Pharmaceuticals Market to Reach US$ 3.18 Trillion by 2033, Fueled by Biologics a …
According to DataM Intelligence, the global pharmaceuticals market size reached US$ 1,740.44 Billion in 2024 and is expected to reach US$ 3,178.63 Billion by 2033, growing at a CAGR of 7.0% during the forecast period 2025-2033. The Pharmaceuticals Market refers to the industry involved in the research, development, production, and distribution of drugs and medications. It includes prescription drugs, over-the-counter (OTC) products, branded and generic drugs, and treatments across various therapeutic
Neurostimulation Devices Market to Reach US$ 17.82 Billion by 2033, Fueled by AI-Integrated and Closed-Loop Technologies
Neurostimulation Devices Market to Reach US$ 17.82 Billion by 2033, Fueled by AI …
According to DataM Intelligence, the global neurostimulation devices market size reached US$ 6.99 billion in 2024 from US$ 6.36 billion in 2023 and is expected to reach US$ 17.82 Billion by 2033, growing at a CAGR of 11.1% during the forecast period 2025-2033. The neurostimulation devices market encompasses implantable and external devices designed to modulate neural activity for therapeutic purposes, addressing conditions from chronic pain and movement disorders to epilepsy and
Rare Disease Therapeutics Market to Reach US$ 495.27 Billion by 2033, Growing at 13.8% CAGR ,Report by DataM Intelligence
Rare Disease Therapeutics Market to Reach US$ 495.27 Billion by 2033, Growing at …
According to DataM Intelligence, the global rare disease therapeutics market reached US$ 135.88 billion in 2023, with a rise of US$ 154.64 billion in 2024, and is expected to reach US$ 495.27 billion by 2033, growing at a CAGR of 13.8% from 2025 to 2033. The Rare Disease Therapeutics Market refers to the sector focused on developing and distributing treatments for rare diseases, which affect a small percentage of the
Lymphedema Treatment Market is expected to reach US$ 2,029.90 million by 2033 | Growth Fueled by Cancer Care & Device Innovation
Lymphedema Treatment Market is expected to reach US$ 2,029.90 million by 2033 | …
Global lymphedema market reached US$ 989.85 million in 2024 and is expected to reach US$ 2,029.90 million by 2033, growing at a CAGR of 8.8 % during the forecast period of 2025-2033. The Lymphedema Market focuses on the diagnosis, treatment, and management of lymphedema, a chronic condition characterized by abnormal accumulation of lymphatic fluid, typically in the arms or legs, due to lymphatic system dysfunction. It often arises as a complication

All 5 Releases


More Releases for Syndrome

"Understanding Rett Syndrome: Trends and Advances in the Rett Syndrome Market"
The Rett Syndrome Market, valued at USD 225.02 million in 2022, is anticipated to surge to USD 515.06 million by 2029, reflecting a significant Compound Annual Growth Rate (CAGR) of 10.23% from 2023 to 2029. Overview of the Rett Syndrome Market: Rett syndrome, a rare genetic neurological and developmental disorder primarily impacting females, hinders brain development and causes progressive loss of motor skills and language. The market report underscores technological advancements
MISME Syndrome Market - Navigating Challenges, Embracing Abilities: MISME Syndro …
Newark, New Castle, USA: The "MISME Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. MISME Syndrome Market: https://www.growthplusreports.com/report/misme-syndrome-market/8883 This latest report researches the industry structure, sales, revenue,
Felty Syndrome Market - A Dedicated Approach to Felty Syndrome Care and Empowerm …
Newark, New Castle, USA: The "Felty Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Felty Syndrome Market: https://www.growthplusreports.com/report/felty-syndrome-market/8440 This latest report researches the industry structure, sales, revenue,
MISME Syndrome Market - Transforming Lives: Empowering Recovery from MISME Syndr …
Newark, New Castle, USA - new report, titled MISME Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the MISME Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global MISME Syndrome market. The report offers an overview of the market, which
Hepatorenal Syndrome Market - Reimagining Wellness, Redefining Survival: Hepator …
Newark, New Castle, USA - new report, titled Hepatorenal Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Hepatorenal Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Hepatorenal Syndrome market. The report offers an overview of the market, which
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syn …
Global Markets Directs, Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and